INHIBRX BIOSCIENCES, INC. (INBX) Holders breakdown
- Shares held by all insiders: Latest value (m).
- Shares held by institutions: Latest value (m).
- Float held by institutions: Latest value (m).
- Institutions holding shares: Latest value (m).
| Breakdown | Latest value |
|---|---|
| Shares held by all insiders | (m) |
| Shares held by institutions | (m) |
| Float held by institutions | (m) |
| Institutions holding shares | (m) |
History
| Date | Shares held by all insiders | Shares held by institutions | Float held by institutions | Institutions holding shares |
|---|---|---|---|---|
| (m) Historical records are unavailable. | ||||
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |